
Cerebral or Brain Aneurysm Treatment in India. A cerebral aneurysm (also called an intracranial aneurysm or brain aneurysm) is a bulging, weakened area in the wall of an artery in the brain, resulting in an abnormal ballooning of the artery that is at risk for rupturing. A cerebral aneurysm more often happens in an artery located in the front part of the brain that supplies oxygen-rich blood to the brain tissue. Arteries anywhere in the brain can develop aneurysms. A normal artery wall is made up of 3 layers. The wall where the aneurysm forms are thin and weak because of an abnormal loss or absence of the muscular layer of the artery wall, leaving only 2 layers. Treatments for an unruptured aneurysm include medication to control blood pressure and procedures to prevent a future rupture. Emergency medical care is required for a ruptured aneurysm.




Market HighlightsBrain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH).
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4561A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market.
According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%.
Despite these drivers, there are some issues associated with brain aneurysm treatment market.Regional AnalysisThe Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm.
According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e.

Brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm.
Aneurysm has the potential to rupture, which causes bleeding in the surrounding sub-arachnoid space, generally resulting in brain damage or stroke.
Key causes of brain aneurysm include heredity, aging, atherosclerosis infection, and brain injury.Read Report Overview - https://www.transparencymarketresearch.com/brain-aneurysm-treatment-market.html Ruptured brain aneurysm is a critical condition and in a few cases, it could be fatal.
It is generally diagnosed with the help of magnetic resonance angiography, cerebral angiography, or computed tomography (CT) scan.
It is mostly prevalent in adults aged 35–60 years.
On the other hand, high cost of the treatment and unrecognized symptoms of the brain aneurysm are considered to be major restraining factors for the market.Based on treatment type, the brain aneurysm treatment market has been segmented into medication and surgery.

